Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on July 17, 2026

Jul. 17, 2026

SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology

Indeterminate GlobeNewswire

Jul. 17, 2026

Abacus Global Management to Announce Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Indeterminate GlobeNewswire

Jul. 17, 2026

Wakefern and ShopRite Expand Edible Garden’s Successful “Garden Starters” Program with Midsummer Promotion

Indeterminate GlobeNewswire

Jul. 17, 2026

Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction

Indeterminate GlobeNewswire

Jul. 17, 2026

Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 17, 2026

Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026

Indeterminate GlobeNewswire

Jul. 17, 2026

BeechBand Founder's Personal Search for Relief Led to Wearable Now Reaching Customers in Six Countries

Indeterminate GlobeNewswire

Jul. 17, 2026

BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland

Indeterminate GlobeNewswire

Jul. 17, 2026

Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026

Indeterminate GlobeNewswire

Jul. 17, 2026

PLNT Legal Deadline Notice: Important Planet Fitness Deadline in Securities Fraud Class Action is Approaching – Investors Notified to Contact BFA Law by September 14

Indeterminate GlobeNewswire

Jul. 17, 2026

Gym Plus Launches Icon, a Compact Functional Trainer with Dual Cables and Smith Machine

Indeterminate GlobeNewswire

Jul. 17, 2026

Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline

Indeterminate GlobeNewswire

Jul. 17, 2026

European Commission approves JASCAYD®, bringing well-tolerated, novel oral treatment for IPF and PPF to the EU

Indeterminate GlobeNewswire

Jul. 17, 2026

Physiotherapist John Abraham Launches RAPIDÈ, Singapore’s First Clinician-Led Recovery Atelier, Setting a New Benchmark for Recovery, Performance and Healthy Ageing

Indeterminate GlobeNewswire

Jul. 17, 2026

Enjoin Reports 923% Average ROI Delivered in Q1 2026

Indeterminate GlobeNewswire